Abivax Announces the Start of the Roadshow for its Proposed Global Offering and Proposed Nasdaq Listing lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
EQS-News: ABIVAX / Key word: Study results
Abivax highlights obefazimod ulcerative colitis program with new data to be presented at the UEG Week 2023
02.10.2023.
Abivax SA (Euronext Paris: FR0012333284 - ABVX) ("Abivax" or the "Company") today announced updated business and operational goals along with changes to Abivax's overall strategy , focused on preparing Abivax for the potential commercialization of its investigational lead asset, obefazimod, in IBD.